Table 3.
Presence of human bocaviruses and other enteric pathogens in patients in different age groups.
| Viruses Age (Months) | n | HNoVGII | RoV | HAdV | HAstV |
|---|---|---|---|---|---|
| 0–6 (HBoV+) | 5 | ||||
| 0–6 (HBoV−) | 3 | 1 | |||
| 6–12 (HBoV+) | 10 | 5 | 1 | 1 | |
| 6–12 (HBoV−) | 5 | 1 | |||
| 12–24 (HBoV+) | 22 | 8 | 5 | 1 | |
| 12–24 (HBoV−) | 13 | 4 | 5 | 1 | |
| 24–60 (HBoV+) | 24 | 11 | 7 | 2 | |
| 24–60 (HBoV−) | 1 |
+/− presence/absence of HBoV in corresponding sample; HBoV–human bocavirus; HNoVGII—norovirus genogroup II; RoV—rotavirus; HAdV—adenovirus; HAstV—astrovirus; n—number of patients. There was no statistically significant difference between the HBoV viral load in blood samples in the case of single and co-infections (p = 0.2721).